Revenue Insights: Lantheus Holdings, Inc. and Geron Corporation Performance Compared

Lantheus vs. Geron: A Decade of Revenue Divergence

__timestampGeron CorporationLantheus Holdings, Inc.
Wednesday, January 1, 20141153000301600000
Thursday, January 1, 201536371000293461000
Friday, January 1, 20166162000301853000
Sunday, January 1, 20171065000331378000
Monday, January 1, 20181066000343374000
Tuesday, January 1, 2019460000347337000
Wednesday, January 1, 2020253000339410000
Friday, January 1, 20211393000425208000
Saturday, January 1, 2022596000935061000
Sunday, January 1, 20232370001296429000
Loading chart...

Data in motion

Revenue Growth: A Tale of Two Companies

In the competitive landscape of the healthcare sector, Lantheus Holdings, Inc. and Geron Corporation present a fascinating study in contrasts. Over the past decade, Lantheus Holdings has demonstrated a robust revenue growth trajectory, with a remarkable increase of over 330% from 2014 to 2023. This growth is highlighted by a significant surge in 2023, where revenues peaked at approximately $1.3 billion, reflecting the company's strategic market positioning and innovative product offerings.

Conversely, Geron Corporation's revenue journey tells a different story. Despite a promising start in 2015, with revenues reaching their zenith, the subsequent years have seen a decline, culminating in a modest $237,000 in 2023. This disparity underscores the challenges faced by Geron in maintaining a competitive edge.

As these companies navigate the evolving healthcare landscape, their revenue trajectories offer valuable insights into strategic successes and challenges.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025